Anti-CEACAM19 [Z5P2D9*A9]
Invented by Ayham Alnabulsi from Vertebrate Antibodies Limited
Invented at Vertebrate Antibodies Limited
- Datasheet
- References (0)
- Inventor Info
Info
Catalogue Number | 153245 |
Applications | ELISA WB |
Antigen/Gene or Protein Targets | Carcinoembryonic Antigen Related Cell Adhesion Molecule 19 |
Synonyms | CEACAM19, CEA related cell adhesion molecule 19, CEAL1 |
Reactivity | Human |
Relevance | CEACAM19 belongs to the carcinoembryonic antigen (CEA) gene family. In humans, this family of proteins are involved in several key biological processes such as cell adhesion, cell growth and differentiation, cellular recognition, apoptosis and angiogenesis. Recent studies have shown that CEACAM19 is upregulated, at the mRNA level, in ovarian and breast cancer. |
Host | Mouse |
Immunogen | Peptide sequence – RSINPARPLP (BLAST analysis revealed 100% identity with Gorilla) |
Positive Control | ELISA- Peptide immunogen, Western Blot- CEACAM19 overexpression lysates |
Subclass | IgG |
Myeloma Used | P3X63Ag8.653 |
Strain | Balb/c |
Research Area | Adhesion, Apoptosis and Programmed Cell Death, Cancer, Cell Type or Organelle Marker |
References
There are 0 reference entries for this reagent.
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference